INVO Bioscience Inc (INVO)
0.985
-0.02
(-1.50%)
USD |
NASDAQ |
May 17, 16:00
0.9836
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Free Cash Flow: -5.200M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -5.200M |
September 30, 2023 | -5.414M |
June 30, 2023 | -5.710M |
March 31, 2023 | -5.680M |
December 31, 2022 | -6.616M |
September 30, 2022 | -6.795M |
June 30, 2022 | -7.501M |
March 31, 2022 | -6.805M |
December 31, 2021 | -6.485M |
September 30, 2021 | -7.153M |
June 30, 2021 | -5.764M |
March 31, 2021 | -5.740M |
December 31, 2020 | -4.864M |
September 30, 2020 | -3.784M |
June 30, 2020 | -3.434M |
March 31, 2020 | -2.672M |
December 31, 2019 | 1.256M |
September 30, 2019 | 1.741M |
June 30, 2019 | 2.242M |
March 31, 2019 | 2.424M |
December 31, 2018 | -0.653M |
September 30, 2018 | -0.3861M |
June 30, 2018 | -0.2964M |
March 31, 2018 | -0.1059M |
December 31, 2017 | -0.1813M |
Date | Value |
---|---|
September 30, 2017 | -0.268M |
June 30, 2017 | -0.3055M |
March 31, 2017 | -0.3837M |
December 31, 2016 | -0.3396M |
September 30, 2016 | -0.336M |
June 30, 2016 | -0.296M |
March 31, 2016 | -0.2011M |
December 31, 2015 | -0.1516M |
September 30, 2015 | -0.0028M |
June 30, 2015 | -0.036M |
March 31, 2015 | -0.0738M |
December 31, 2011 | -0.1178M |
September 30, 2011 | -0.049M |
June 30, 2011 | -0.1314M |
March 31, 2011 | -0.1967M |
December 31, 2010 | -0.316M |
September 30, 2010 | -0.6844M |
June 30, 2010 | -0.8684M |
March 31, 2010 | -0.8281M |
December 31, 2009 | -0.9267M |
September 30, 2009 | -1.797M |
June 30, 2009 | -1.322M |
March 31, 2009 | -1.410M |
December 31, 2008 | -1.067M |
September 30, 2008 | -0.0184M |
Free Cash Flow Range, Past 5 Years
-7.501M
Minimum
Jun 2022
2.242M
Maximum
Jun 2019
-4.441M
Average
-5.680M
Median
Mar 2023
Free Cash Flow Benchmarks
Abbott Laboratories | 4.923B |
Perspective Therapeutics Inc | -23.28M |
Xtant Medical Holdings Inc | -14.80M |
Asensus Surgical Inc | -60.39M |
Catheter Precision Inc | -10.57M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.7149M |
Cash from Investing (Quarterly) | 0.0333M |
Cash from Financing (Quarterly) | -0.1415M |
Free Cash Flow Per Share (Quarterly) | -0.3169 |
Free Cash Flow to Equity (Quarterly) | -0.7562M |
Free Cash Flow to Firm (Quarterly) | -0.6057M |
Free Cash Flow Yield | -375.4% |